To explore the additive effect of insulin and JAKi in RA patients, we compared CD4+ cells within the JAKi-treated (seven with hyperinsulinemia) and non-JAKi-treated groups (five with hyperinsulinemia). This evidence concerns the gene CD4 and rheumatoid arthritis.